Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc.

Bullboard Posts

Comment by Thesweethearton Aug 28, 2019 1:17pm

103 Views

Post# 30075451

RE:doom sayers only want your shares

Yes!!! That is correct newcamo, all everyone wants! is your shares!

Newcamo wrote:
TSX approved the rights offering that is attached to the restructure and listing requirements are formally approved as well (gives PLI immunity as TSX said it was all good). This all happened about 6 months ago/ Edrose and friends are only here to get your shares... nasdaq, lazard deal in weeks, and in a couple of months ryplazim.. see august 7th slides -> "... negociations coming to conclusion..." means partnership + nasdaq confirmed. Read it from the slides. www.prometic.com

2019-08-15 13:06 ET - Miscellaneous

The Toronto Stock Exchange reports that ProMetic Life Sciences Inc. has regained compliance with its continued listing requirements.